Results 161 to 170 of about 4,466,969 (285)

Langerhans Cell Histiocytosis [PDF]

Ear, Nose & Throat Journal, 2010
Sandra, Camelo-Piragua, Eduardo, Zambrano, Liron, Pantanowitz   +2 more
openaire   +2 more sources

Autoantigen mRNA‐LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity

Advanced Science, Volume 13, Issue 53, 24 September 2026.
Systemic and intramuscular delivery of autoantigen mRNA via lipid nanoparticles reprograms antigen‐presenting cells toward a mature, homeostatic state, driving antigen‐specific T cell exhaustion and providing therapeutic efficacy across autoimmune disease models.
Paulien Baeten, Karen Beets, Tessa Schalley, Janne Verreycken, Gayel Duran, Daphne Lintsen, Lisa Schuetz, Xue Zhong, Rinke Nieuwschepen, Melissa Schepers, Brecht Moonen, Jeroen Bogie, Jana Van Broeckhoven, Carlo Heirman, Jurgen Van den Heuvel, Bart Vanderborght, Ismael Varela, Roxanne Nouille, Lotte Jacobs, Jessica Filtjens, Sabah Kasmi, Elise Seynaeve, Veronica Mavrovouna, Jana De Vrieze, Michael A. Brehm, Sandra Maréchal, Sophie Janssens, Florence Lambolez, Niels Hellings, Stefaan De Koker, Bieke Broux   +30 more
wiley   +1 more source

Chronic Kidney Disease in Children Within Five Years After Ifosfamide Chemotherapy for Childhood Cancer: A Dutch Pediatric Oncology Cohort Study

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Introduction Children treated with ifosfamide seem to have an increased risk for developing chronic kidney disease (CKD) already within the first years following chemotherapy. However, studies investigating CKD prevalence in this specific phase are scarce.
Lotte Pitlo, Francis S. P. L. Wens, Paulien A. M. A. Raymakers‐Janssen, Lianne M. Haveman, Johannes H. M. Merks, Martine van Grotel, Geert O. Janssens, Marta Fiocco, Marry M. van den Heuvel‐Eibrink, Gerrit van den Berg   +9 more
wiley   +1 more source

Distinct postnatal trajectories of mouse dendritic epidermal T cells and Langerhans cells independent of microbiota. [PDF]

Sci Adv
Obwegs D, Oschwald A, Koetter LM, Crisand C, Doerr S, Bruder K, Runge S, Ghanem N, Fuchs V, Eckert M, Koengeter C, Schaffer AM, Amann L, Papaioannou S, Rollenske T, Kolter J, Erny D, Prinz M, Minguet S, Schamel WW, Henneke P, Rosshart SP, Kierdorf K, Sagar.   +23 more
europepmc   +1 more source

Effect of ultrasound treatment of the skin on activation of Langerhans cells and antibody production in rodents. [PDF]

J Adv Pharm Technol Res, 2023
Enjo S, Hazama Y, Kimura S, Morimoto Y, Ueda H.   +4 more
europepmc   +1 more source

Mechanistic Pathways of Wound Healing: From Hemostasis to Scar‐Free Regeneration

Cell Biochemistry and Function, Volume 44, Issue 9, September 2026.
ABSTRACT Wound healing is the critical process regulated through a harmonious coordination of cellular, molecular, pathological, and systemic communications. Normally, healing occurs in four overlapping phases, which are modified and controlled by various growth factor interactions and signaling pathways.
Devadass Jessy Mercy, Koyeli Girigoswami, Agnishwar Girigoswami   +2 more
wiley   +1 more source

Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responses. [PDF]

EBioMedicine
Hammoudi A, Surenaud M, Legros J, Picard F, Hypolite G, Manso J, Agyar T, Kembou A, Esposito M, Sicherre E, Flor G, Pedenko B, Guilligay D, Bouceba T, Fenwick C, Moog C, Zurawski S, Zurawski G, Pantaleo G, Weissenhorn W, Centlivre M, Godot V, Lévy Y, Cardinaud S.   +23 more
europepmc   +1 more source

Cross-presenting Langerhans cells are required for the early reactivation of resident CD8⁺ memory T cells in the epidermis. [PDF]

Proc Natl Acad Sci U S A, 2023
Kamenjarin N, Hodapp K, Melchior F, Harms G, Hartmann AK, Bartneck J, Muth S, Raker VK, Becker C, Brand A, Clausen BE, Radsak MP, Schild H, Probst HC.   +13 more
europepmc   +1 more source

Langerhans Cell

Journal of Investigative Dermatology, 1981
openaire   +2 more sources

IL‐22Rα1 restrains pancreatic injury independently of its C‐terminal STAT3‐amplifying domain

Journal of Cell Communication and Signaling, Volume 20, Issue 3, September 2026.
IL‐22R, and to a lesser extent IL‐22, are key drivers of protection in acute pancreatitis. Although the C‐terminal domain of IL‐22R enhances STAT3 activation in the pancreas, it is not required for disease protection. Classical IL‐22R signaling alone is sufficient to control inflammation and promote pancreatic recovery.
Léna Puigdevall, Clara Stewardson, Lysa Dhulst, Emilie Hendrickx, Laure Dumoutier   +4 more
wiley   +1 more source